INSIDE CHINA
Featured

Beijing’s ‘Vaccine Diplomacy’ Fails to Quell Safety Concerns About China-Made Vaccine

Beijing’s ‘Vaccine Diplomacy’ Fails to Quell Safety Concerns About China-Made Vaccine
A medical worker shows the Sinopharm vaccine from China during the first day vaccination against the COVID-19 at Calmette hospital in Phnom Penh, Cambodia, on Feb. 10, 2021. TANG CHHIN SOTHY/AFP via Getty Images
|Updated:

As China seeks to bolster its international standing through “vaccine diplomacy,” public confidence in the safety and efficacy of China’s COVID-19 vaccines—both in and outside China—appears mixed.

The Chinese regime is aggressively promoting its COVID-19 vaccines to foreign countries.

Nicole Hao
Nicole Hao
Author
Nicole Hao is a Washington-based reporter focused on China-related topics. Before joining the Epoch Media Group in July 2009, she worked as a global product manager for a railway business in Paris, France.
Related Topics